154 related articles for article (PubMed ID: 37990344)
21. The hidden dangers of short-term glucocorticoid use in children: A genomic analysis.
Xu X; Li Y; Han T; Zhao Y; Wang X; Fu X; Mao H
Int Immunopharmacol; 2024 May; 135():112323. PubMed ID: 38788448
[TBL] [Abstract][Full Text] [Related]
22. Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models.
Liang Z; Liu J; Huang JX; Zeng X
Comb Chem High Throughput Screen; 2018; 21(2):93-99. PubMed ID: 29336255
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.
Egger T; Dormann H; Ahne G; Pahl A; Runge U; Azaz-Livshits T; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
Drugs Aging; 2005; 22(3):265-72. PubMed ID: 15813658
[TBL] [Abstract][Full Text] [Related]
24. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
25. Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study.
Prows CA; Zhang X; Huth MM; Zhang K; Saldaña SN; Daraiseh NM; Esslinger HR; Freeman E; Greinwald JH; Martin LJ; Sadhasivam S
Laryngoscope; 2014 May; 124(5):1242-50. PubMed ID: 24122716
[TBL] [Abstract][Full Text] [Related]
26. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
[TBL] [Abstract][Full Text] [Related]
27. Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Flor A; Morales D; Peiró AM
Clin J Pain; 2020 Jun; 36(6):420-429. PubMed ID: 32149782
[TBL] [Abstract][Full Text] [Related]
28. The ABCB1, rs9282564, AG and TT Genotypes and the COMT, rs4680, AA Genotype are Less Frequent in Deceased Patients with Opioid Addiction than in Living Patients with Opioid Addiction.
Christoffersen DJ; Damkier P; Feddersen S; Möller S; Thomsen JL; Brasch-Andersen C; Brøsen K
Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):381-8. PubMed ID: 27061230
[TBL] [Abstract][Full Text] [Related]
29. [Relationship of OPRM1 118A/G gene polymorphism and oxycodone analygesic dose in paitents with cancer pain].
Lin T; Li X; Song J; Zhang C; Bie M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):887-890. PubMed ID: 30512171
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.
Lloyd RA; Hotham E; Hall C; Williams M; Suppiah V
Pain Med; 2017 Dec; 18(12):2369-2387. PubMed ID: 28339912
[TBL] [Abstract][Full Text] [Related]
31.
Firfirey F; September AV; Shamley D
Pharmacogenomics; 2022 Jun; 23(9):513-530. PubMed ID: 35727214
[No Abstract] [Full Text] [Related]
32. Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothers.
Lam J; Kelly L; Matok I; Ross CJ; Carleton BC; Hayden MR; Madadi P; Koren G
Ther Drug Monit; 2013 Aug; 35(4):466-72. PubMed ID: 23783165
[TBL] [Abstract][Full Text] [Related]
33. Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.
Andreaggi CA; Novak EA; Mirabile ME; Sampathkumar S; Gray MP; He M; Kane-Gill SL
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1627-1635. PubMed ID: 32851782
[TBL] [Abstract][Full Text] [Related]
34. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
35. CYP2D6-inhibiting drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment--a Swedish, register-based case-crossover study.
Möller J; Laflamme L; Söderberg Löfdal K
Basic Clin Pharmacol Toxicol; 2015 Feb; 116(2):134-9. PubMed ID: 24975450
[TBL] [Abstract][Full Text] [Related]
36. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment.
Fiegenbaum M; da Silveira FR; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
Clin Pharmacol Ther; 2005 Nov; 78(5):551-8. PubMed ID: 16321621
[TBL] [Abstract][Full Text] [Related]
37. Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions.
Gao B; Tan T; Cao X; Pan M; Yang C; Wang J; Shuai Z; Xia Q
BMC Med Genomics; 2022 Feb; 15(1):23. PubMed ID: 35135554
[TBL] [Abstract][Full Text] [Related]
38. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2015 Feb; (2):CD003870. PubMed ID: 25723351
[TBL] [Abstract][Full Text] [Related]
39. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
40. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
